CGM trial for diabetic emergencies withdrawn before it began
NCT ID NCT06693115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if continuous glucose monitors (CGMs) could help hospital staff manage patients with diabetic ketoacidosis or hyperosmolar hyperglycemic state. Researchers planned to enroll adults in the emergency department and track how often CGMs were used, how accurate they were, and whether they improved care. However, the study was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- continuous glucose monitor (CGM) device
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KETOACIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Regions Hospital
Saint Paul, Minnesota, 55101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a breath test replace finger pricks for diabetes?
- Could a wearable sensor replace fingerstick checks for sepsis patients in the ICU?
- Could a simple sugar help people with type 1 diabetes exercise safely?
- Could a simple vitamin speed recovery from a dangerous diabetes complication?
- New diabetes program helps hill tribe elders control blood sugar
- Your personality might predict your lab results